Global Topical Drug Delivery Market is segmented by product (semi-solid formulations, liquid formulations, solid formulations and transdermal products), by route of administration (dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery and nasal drug delivery), by facility of use (home care settings, hospitals and clinics, burn centers and other facilities), by geography (North America, Europe, Asia Pacific, Middle East & Africa and South America)) is expected to reach US $ XX Bn by 2026, at a CAGR of 5.80 %.
The Homecare setting segment is expected to grow at a XX% rate of CAGR during the forecast period.
Homecare settings are the foremost facility of usage of topical formulations. The home care setting segment is expected to share significant growth in the global topical drug delivery market. An increasing need for self-administration of drugs at home, convenience and enhanced affordability in self-administration owing to saving in time and cost, and a growing number of patients are selecting for home-based treatments are some of the prominent key factors driving the growth of the global topical drug delivery market by Homecare setting segment.
The Creams segment is expected to be an extensively used type of semi-solid formulations in the global topical drug delivery market.
The Cream segment is expected to share significant growth in the global topical drug delivery market. The growth in the market is attributed to the ease of spreadability and washability of creams over other semi-solid formulations like ointments, gels, lotions, and pastes.
North America region is estimated to hold the dominant position in the global topical drug delivery market.
The North America region is projected to share significant growth in the global topical drug delivery market. The increasing prevalence of skin diseases coupled with the development of the technically advanced topical and transdermal products in the region is expected to boost the growth of the topical drug delivery market in the region. The presence of a large number of pharmaceutical key players and drug delivery technology providers are also expected to contribute significant growth in the global topical drug delivery market.
Key players operating in the Global Topical Drug Delivery Market includes Hisamitsu Pharmaceutical , Nestle SA , Novartis AG , Glenmark Pharmaceuticals , Cipla Inc., Glaxosmithkline, MedPharm Group Ltd , Janssen Global Services , Bausch Health Companies , Pocono Coated Products LLC, Merck & Co. , Skinvisible Pharmaceuticals, Inc., Bayer AG , Crescita Therapeutics Inc. , Galderma S.A., Lohmann Therapie-Systeme AG, Mylan N.V. and Valeant Pharmaceuticals International, Inc.
Maximize Market Research, a global market research firm with a dedicated team of specialists and data has carried out extensive research about the global topical drug delivery market. The report encompasses the market by different segments and region, providing an in-depth analysis of the overall industry ecosystem, useful for making an informed strategic decision by the key stakeholders in the industry. Importantly, the report delivers forecasts and share of the market, further giving an insight into the market dynamics, and future opportunities that might exist in the global topical drug delivery market. The driving forces, as well as considerable restraints, have been explained in depth. In addition to this, competitive landscape describing the strategic growth of the competitors have been taken into consideration for enhancing market know-how of our clients and at the same time explain global topical drug delivery market positioning of competitors.
Browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Topical Drug Delivery Market”
https://www.maximizemarketresearch.com/market-report/global-topical-drug-delivery-market/33725/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, VadgaonBk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607065656